Meghalaya Magazine

Knee Osteoarthritis Market is Expected to Expand at a Healthy Growth Rate by (2022-2032), States DelveInsight | Key Companies – Centrexion Therapeutics, Taiwan Liposome Company, Grünenthal

 Breaking News
  • No posts were found

Knee Osteoarthritis Market is Expected to Expand at a Healthy Growth Rate by (2022-2032), States DelveInsight | Key Companies – Centrexion Therapeutics, Taiwan Liposome Company, Grünenthal

February 07
03:09 2023
Knee Osteoarthritis Market is Expected to Expand at a Healthy Growth Rate by (2022-2032), States DelveInsight | Key Companies - Centrexion Therapeutics, Taiwan Liposome Company, Grünenthal
The Knee Osteoarthritis market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Knee Osteoarthritis pipeline products will significantly revolutionize the Knee Osteoarthritis market dynamics.

DelveInsight’s “Knee Osteoarthritis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Knee Osteoarthritis, historical and forecasted epidemiology as well as the Knee Osteoarthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Knee Osteoarthritis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

 

To Know in detail about the Knee Osteoarthritis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Knee Osteoarthritis Market Insights

 

Knee Osteoarthritis Overview

Knee osteoarthritis (OA), also known as degenerative joint disease, is typically the result of wear and tear and progressive loss of articular cartilage. It is most common in the elderly and can be divided into two types, primary and secondary. Primary osteoarthritis is articular degeneration without any apparent underlying reason. Secondary osteoarthritis is the consequence of either an abnormal concentration of force across the joint as with post-traumatic causes or abnormal articular cartilage, such as rheumatoid arthritis (RA).

 

Some of the key facts of the Knee Osteoarthritis Market Report: 

  • The Knee Osteoarthritis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • The Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study in Japan showed a significant rise in knee Osteoarthritis through working age. As per this study, in Japan, OA affects approximately 25.3 million individuals aged over 40 years
  • According to Centers for Disease Control and Prevention, 32.5 million US adults, or one in seven persons (14%), reported osteoarthritis
  • The prevalent population of symptomatic Knee OA in the seven major markets was found to be 47,874,567 in 2021. In 2021, the highest prevalent cases of the disease were observed in the United States, with 17,660,391 cases, and the EU-4 and the UK accounted for 19,946,245 cases
  • Key Knee Osteoarthritis Companies: Centrexion Therapeutics, Taiwan Liposome Company, Grünenthal, Biosplice Therapeutics, Techfields, MiMedx, Tissue Tech, Ampio Pharmaceuticals, Organogenesis, Medipost, Naturecell, and others
  • Key Knee Osteoarthritis Therapies: CNTX-4975, TLC599, Resiniferatoxin, RTX-GRT7039, Lorecivivint, X0002, Amniofix, TTAX03, Ampion, ReNu, Cartistem, JointStem, and others
  • The Knee Osteoarthritis epidemiology based on gender analyzed that females are most commonly affected than males in case of Knee Osteoarthritis

 

Get a Free sample for the Knee Osteoarthritis Market Report –

https://www.delveinsight.com/sample-request/knee-osteoarthritis-market

 

Key benefits of the Knee Osteoarthritis Market report:

  1. Knee Osteoarthritis market report covers a descriptive overview and comprehensive insight of the Knee Osteoarthritis Epidemiology and Knee Osteoarthritis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Knee Osteoarthritis market report provides insights on the current and emerging therapies.
  3. Knee Osteoarthritis market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Knee Osteoarthritis market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Knee Osteoarthritis market.

 

Download the report to understand which factors are driving Knee Osteoarthritis epidemiology trends @ Knee Osteoarthritis Epidemiological Insights 

 

Knee Osteoarthritis Market  

The dynamics of the Knee Osteoarthritis market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. 

“According to the estimates, the highest market size of Knee Osteoarthritis was found in the United Statesand the least was in Italy across the 7MM. Besides, the upcoming therapies of Knee Osteoarthritis are expected to combat the current unmet needs faced by the patients with Knee Osteoarthritis and add to the overall growth of the Knee Osteoarthritis market size.”

 

Knee Osteoarthritis Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Knee Osteoarthritis Epidemiology Segmentation:

The Knee Osteoarthritis market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Knee Osteoarthritis
  • Prevalent Cases of Knee Osteoarthritis by severity
  • Gender-specific Prevalence of Knee Osteoarthritis
  • Diagnosed Cases of Episodic and Chronic Knee Osteoarthritis

 

Knee Osteoarthritis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Knee Osteoarthritis market or expected to get launched during the study period. The analysis covers Knee Osteoarthritis market uptake by drugs, patient uptake by therapies, and sales of each drug.  

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Knee Osteoarthritis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Discover more about therapies set to grab major Knee Osteoarthritis market share @ Knee Osteoarthritis market forecast

 

Knee Osteoarthritis Therapies and Key Companies

  • CNTX-4975: Centrexion Therapeutics
  • TLC599: Taiwan Liposome Company
  • Resiniferatoxin/RTX-GRT7039: Grünenthal
  • Lorecivivint: Biosplice Therapeutics
  • X0002: Techfields
  • Amniofix: MiMedx
  • TTAX03: Tissue Tech
  • Ampion: Ampio Pharmaceuticals
  • ReNu: Organogenesis
  • Cartistem: Medipost
  • JointStem: Naturecell

 

Knee Osteoarthritis Market Strengths

  • Now companies are investing heavily in developing disease modifying therapies for the treatment of knee Osteoarthritis, which will fulfill a major unmet need
  • Many key players are developing cell therapies for knee Osteoarthritis, which are in various stages of development. These therapies, if approved, may provide a better treatment options as it can slow disease progression and may possibly cure the disease

 

Scope of the Knee Osteoarthritis Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Knee Osteoarthritis Companies: Centrexion Therapeutics, Taiwan Liposome Company, Grünenthal, Biosplice Therapeutics, Techfields, MiMedx, Tissue Tech, Ampio Pharmaceuticals, Organogenesis, Medipost, Naturecell, and others
  • Key Knee Osteoarthritis Therapies: CNTX-4975, TLC599, Resiniferatoxin, RTX-GRT7039, Lorecivivint, X0002, Amniofix, TTAX03, Ampion, ReNu, Cartistem, JointStem, and others
  • Knee Osteoarthritis Therapeutic Assessment: Knee Osteoarthritis current marketed and Knee Osteoarthritis emerging therapies
  • Knee Osteoarthritis Market Dynamics: Knee Osteoarthritis market drivers and Knee Osteoarthritis market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Knee Osteoarthritis Unmet Needs, KOL’s views, Analyst’s views, Knee Osteoarthritis Market Access and Reimbursement 

 

Knee Osteoarthritis Market Barriers

  • For the treatment of Knee Osteoarthritis, usage of opioids can be seen. The majority of patients/ physicians are eagerly waiting for non-opioids options and key players can target this lucrative segment of the market, while others are already developing therapies for the same

 

Table of Contents 

1. Knee Osteoarthritis Market Report Introduction

2. Executive Summary for Knee Osteoarthritis

3. SWOT analysis of Knee Osteoarthritis

4. Knee Osteoarthritis Patient Share (%) Overview at a Glance

5. Knee Osteoarthritis Market Overview at a Glance

6. Knee Osteoarthritis Disease Background and Overview

7. Knee Osteoarthritis Epidemiology and Patient Population

8. Country-Specific Patient Population of Knee Osteoarthritis 

9. Knee Osteoarthritis Current Treatment and Medical Practices

10. Knee Osteoarthritis Unmet Needs

11. Knee Osteoarthritis Emerging Therapies

12. Knee Osteoarthritis Market Outlook

13. Country-Wise Knee Osteoarthritis Market Analysis (2019–2032)

14. Knee Osteoarthritis Market Access and Reimbursement of Therapies

15. Knee Osteoarthritis Market Drivers

16. Knee Osteoarthritis Market Barriers

17.  Knee Osteoarthritis Appendix

18. Knee Osteoarthritis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

To know more about Knee Osteoarthritis treatment, visit @ Knee Osteoarthritis Medications

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting